Cancer News | Cancer Updates | Recent updates in cancer treatment, diagnosis | iPharmaCenter
Best selling drugs of 2023 | Top 10 drugs by revenues | Best selling pharmaceuticals | iPharmaCenter
Top pharma companies by revenues in 2023|Big Pharma Profits |Top 20 pharma companies | iPharmaCenter
Esophageal squamous cell carcinoma | News | Updates | iPharmaCenter
Top selling immunology drugs | Top 10 immunology drugs by revenues | iPharmaCenter
Top CMS Pharmaceutical Expenditures: Analyzing High-Expenditure Medications
Hypertension | News | Updates | iPharmaCenter
HPV News | Updates | iPharmaCenter
Chronic rhinosinusitis with nasal polyps | News | Updates | iPharmaCenter
PCSK9 inhibitors | Heart Failure News | Updates | iPharmaCenter
Deals and Acquisitions | 2023 | Pharma | News | Healthcare | iPharmaCenter
Migraine News | Updates | Atogepant | iPharmaCenter
Chronic spontaneous urticaria | News | Updates |
10 Most Expensive Drugs | 2023 | Pharmaceuticals | iPharmaCenter
Multiple Sclerosis | News | Blogs | Updates | 2023
Women Health | Menopause News | iPharmaCenter
Meningococcal infection | iPharmaCenter
Pharmaceutical Companies Deals and acquisitions | Sanofi | Amgen | Pfizer | 2022 | iPharmaCenter
How is AbbVie bracing for the impact of Humira’s biosimilars? | iPharmaCenter
TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022
Top-selling cancer drugs | 2022 | 2023 | Best cancer products | iPharmaCenter
Top 5 drug launches in 2023 that has potential to be blockbusters | iPharmaCenter
Expected best selling drugs of 2023
Access to Medicines | 2021 | 2022 | News | iPharmaCenter | GSK tops list
Multiple Myeloma | News | Blogs | FDA and EMA approvals | Updates on clinical guidelines
Merck and Moderna agreed to develop and commercialize a cancer vaccine | iPharmaCenter
Sanofi gave a statement on the U.S. Zantac litigation | iPharmaCenter
AbbVie's JAK inhibitor, Rinvoq, was approved for UC and nr-axSpA in Europe | iPharmaCenter
Top 20 healthcare companies | iPharmaCenter | Top healthcare companies by revenues
Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter
Expected best selling pharmaceuticals/drugs of 2022
Top pharmaceutical companies by revenues in 2021 | Top 10 pharma companies | iPharmaCenter
Collaborations for drug development in Pharma and Healthcare |
COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine
COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
Top 20 pharmaceutical companies by revenues in 2020
Myasthenia Gravis News | FDA and EMA approvals |
Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News
China released the 2022 NDRL list, Chinese pharma benefited from the list
European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19
American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
WHO granted EUL to Covaxin; acclaims easy storage requirement
FDA approved Novartis Scembli for chronic myeloid leukemia
Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval
European Commission approved Benlysta for active lupus nephritis
France COVID-19 Updates | COVID-19 News in Europe
American Academy of Dermatology (AAD VMX) Virtual Meeting
GSK’s Jemperli received approval in Europe and the US for endometrial cancer
Multiple sclerosis News | Tysabri is now available as SC in Europe